← Leaderboards
Alvin V Terry
University Of Georgia (Uga)
$6,749,097
Attributed
$6,749,097
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $969.2K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$6,749,097 · 6
By mechanism
R01$6,136,912 · 4
R21$351,383 · 1
G20$260,802 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseRattusAttentionCognitionCognitiveMemoryRodent ModelSymptomsBehavioralChronicImpairmentAcuteSchizophreniaDesignLeadToxic EffectAcetylcholineImpaired CognitionResearch StudyNonhuman PrimateAffectPerformanceProceduresRodent
Grant awards (24)
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse$320,828
R01 · FY2014 · DA · contact PI
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse$307,995
R01 · FY2013 · DA · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$300,161
R01 · FY2013 · ES · contact PI
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse$320,828
R01 · FY2012 · DA · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$306,283
R01 · FY2012 · ES · contact PI
Renovation of the cage wash facility at the MCG animal facility in Gracewood, GA$260,802
G20 · FY2012 · OD · contact PI
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse$356,475
R01 · FY2011 · DA · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$306,279
R01 · FY2011 · ES · contact PI
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse$367,500
R01 · FY2010 · DA · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$309,369
R01 · FY2010 · ES · contact PI
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric Disorders$292,370
R01 · FY2010 · AG · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$322,478
R01 · FY2009 · ES · contact PI
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric Disorders$295,323
R01 · FY2009 · AG · contact PI
Procognitive and Antipsychotic Actions of JWS-USC-75-IX$160,073
R21 · FY2009 · AG · contact PI
Cholinesterase Inhibitors, Axonal Transport, and Memory$17,052
R01 · FY2009 · ES · contact PI
Procognitive and Antipsychotic Actions of JWS-USC-75-IX$191,310
R21 · FY2008 · AG · contact PI
Cholinesterase Inhibitors, Axonal transport, and Memory$308,522
R01 · FY2007 · ES · contact PI
Cholinesterase Inhibitors, Axonal transport, and Memory$334,555
R01 · FY2006 · ES · contact PI
Antipsychotics: Temporal Effects on Cognitive Function$321,147
R01 · FY2006 · MH · contact PI
Cholinesterase Inhibitors, Axonal transport, and Memory$272,316
R01 · FY2005 · ES
Antipsychotics: Temporal Effects on Cognitive Function$262,394
R01 · FY2005 · MH
Cholinesterase Inhibitors, Axonal transport, and Memory$286,396
R01 · FY2004 · ES
Antipsychotics: Temporal Effects on Cognitive Function$260,803
R01 · FY2004 · MH
Antipsychotics: Temporal Effects on Cognitive Function$267,838
R01 · FY2003 · MH